Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

A Reflection of Gratitude

TON - Daily
Beth Faiman, PhD, APRN-BC, AOCN
Editor in Chief

Dear Colleague,

During this time of year, we often reflect on those things for which we are most grateful. As I look back on 2011, I am most thankful for my family and my health. However, I am also grateful for all The Oncology Nurse–APN/PA has accomplished this year as each of us strive to improve patient care. Throughout 2011, we have explored compassionate healthcare, investigated survivorship issues, studied newer nursing interventions, perused meeting highlights, and uncovered future investigational therapies. The Oncology Nurse APN/PA has allowed all of us to make new connections within our field, share best practices, and learn from each others’ experiences.

On behalf of all of us at The Oncology Nurse–APN/PA, we wish you all a Happy Thanksgiving.

With best regards,

Beth Faiman, RN, MSN, APRN, BC, AOCN
Editor-in-Chief

Related Items
Staying Abreast of New Treatments
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Managing Patients with Multiple Myeloma
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Perceptions of Daratumumab Therapy
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Starting a Patient on Daratumumab
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
What Do Patients Ask About Daratumumab?
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Unmet Needs in Patients with Myeloma
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
The Challenge of Managing Treatment-Related Toxicites
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Self-Managing Side Effects
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Concerns Over New Multiple Myeloma Therapies
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
How Janssen CarePath Helps Patients
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  published on April 18, 2017 in Hematologic Cancers, Conference Correspondent, ASH
Last modified: September 8, 2015